Pharmanutra S.p.A. (id:4951 PHN)
53.80 EUR
Opening hours: 09:00 - 05:30 (Central European Standard Time: 11/23/2024 11:35:32 AM)
Exchange closed, opens in 1 day 21 hours
About Pharmanutra S.p.A.
Market Capitalization 539.90M
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company's products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Cetilar Tape, Cetilar Oro, Cetilar Nutrition, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. It distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. The company was founded in 2003 and is based in Pisa, Italy.
| Headquarters (address) |
Via Campodavela 1 Pisa 56122 PI Italy |
| Phone | 39 05 07 84 65 00 |
| Website | https://www.pharmanutra.it |
| Employees | 112 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | PHN |
| Exchange | Italian Stock Exchange |
| Currency | EUR |
| 52 week range | 44.85 - 63.50 |
| Market Capitalization | 539.90M |
| Dividend yield forward | 6.31 % |
| Dividend yield forward Italy (ID:74, base:166) | 13.85 % |
| P/E trailing | 32.96 |
| P/E forward | 26.15 |
| Price/Sale | 5.02 |
| Price/Book | 9.84 |
| Beta | 0.336 |
| EPS | 1.69 |
| EPS Italy (ID:74, base:207) | 0.781 |
Dividend growth streak
Pharmanutra S.p.A. has raised their dividend 4.00 years in a row. This is below the 4.478450 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Pharmanutra S.p.A. has raised their dividend 6.31 years in a row. This is below the 41189.441200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Pharmanutra S.p.A. has raised their dividend 20.26 years in a row. This is below the 24.013800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Pharmanutra S.p.A. has raised their dividend 19.38 years in a row. This is above the 12.574800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Pharmanutra S.p.A. has raised their dividend 50.30 years in a row. This is below the 147.934700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Dividend growth streak
Pharmanutra S.p.A. has raised their dividend 4.00 years in a row. This is below the 4.478450 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Pharmanutra S.p.A. has raised their dividend 6.31 years in a row. This is below the 41189.441200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Pharmanutra S.p.A. has raised their dividend 20.26 years in a row. This is below the 24.013800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Pharmanutra S.p.A. has raised their dividend 19.38 years in a row. This is above the 12.574800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Pharmanutra S.p.A. has raised their dividend 50.30 years in a row. This is below the 147.934700 year average in the 'Drug Manufacturers Specialty & Generic' industry